1
0
0
(1 - 38 von 52
)
Cambrian BioPharma Unveils New Pipeline CompanyABC27
www.abc27.com
— ... Georg C. Terstappen, PhD. "Using this state-of-the-art approach to drug discovery combined with an impressive team gives us great confidence ...
Cambrian BioPharma unveils new pipeline companyLongevity.Technology
longevity.technology
... Georg C Terstappen, PhD. “Using this state-of-the-art approach to drug discovery combined with an impressive team gives us great confidence in the future of ...
Cambrian Biopharma - Contacts, Employees, Board Members ...www.crunchbase.com › cambrian-biopharma › people
www.crunchbase.com
Georg C. Terstappen. Executive Vice President, Drug Discovery. VP Operations. 1 email found. View. Alexandra Baranowski. Portfolio Operations Fellow.
Cambrian BioPharma Unveils New Pipeline CompanyPR Newswire
www.prnewswire.com
— ... Georg C. Terstappen, PhD. "Using this state-of-the-art approach to drug discovery combined with an impressive team gives us great confidence ...
In silico research in drug discoveryCell Press
www.cell.com
Georg C. Terstappen, Angelo Reggiani. Trends in Pharmacological Sciences. Volume 22 Issue 1 Pages (January 2001). DOI: S (00) Fig ...
Medical Advisory CommitteeChildren's Tumor Foundation
www.ctf.org
Georg C Terstappen, PhD. Executive Vice President, Drug Discovery, Cambrian Biopharma. Read Bio. A black and white photo of a man with a beard. David Viskochil ...
Biographie von Georg Terstappen - The Official Board
www.theofficialboard.de
Georg Terstappen ist derzeit Executive Vice President, Drug Discovery bei Cambrian Biopharma. Bei Cambrian Biopharma hat Georg Terstappen 40 Kollegen einschließlich James Peyer …
NEUWAY Pharma GmbHAcademicLabs
app.academiclabs.com
Leadership. Chief Science Officer. Georg C. Terstappen. Georg is the Executive Vice President of Drug Discovery at Cambrian Biopharma. He has nearly 30 years ...
Scientific Advisory BoardNeuway Pharma
www.neuway-pharma.com
Georg C. Terstappen, Ph. D Chairman of the board Georg is the Executive Vice President of Drug Discovery at Cambrian Biopharma. Georg C. Terstappen, Ph. D Chairman of the board Georg is the Executive Vice President of Drug Discovery at Cambrian Biopharma.
Team - Cambrian Biopharmawww.cambrianbio.com › team
www.cambrianbio.com
Georg C. Terstappen, PhD ... Georg C. Terstappen is the Executive Vice President of Drug Discovery at Cambrian BioPharma. He has 30 years of experience in big ...
In silico research in drug discovery. - DialnetDialnet
dialnet.unirioja.es
Georg C. Terstappen, Angelo Reggiani; Localización: Trends in pharmacological sciences, ISSN , Vol. 22, Nº 1, 2001, pág. 23; Idioma: inglés; Texto ...
bokus.com: Label-Free Technologies For Drug Discovery - Matthew Cooper, Lorenz M...
Köp Label-Free Technologies For Drug Discovery av Matthew Cooper, Lorenz M Mayr. Skickas inom vardagar. Fri frakt över 199 kr. Välkommen till Bokus...
Georg C. Terstappen - Acemap
www.acemap.info
Georg C. Terstappen · Alzheimers & Dementia · Journal of Biomolecular Screening · Drug Discovery Today · Biochemical Pharmacology · Neuroscience Letters.
Label-Free Technologies For Drug Discovery - Google Books
books.google.ie
Over the past two decades the benefits of label-free biosensor analysis have begun to make an impact in the market, and systems are beginning to be used as...
How to Achieve Confidence in Drug Discovery and ...Chemistry Europe
chemistry-europe.onlinelibrary.wiley.com
von A Bakker · · Zitiert von: 9 — Annette Bakker Dr Andrea Caricasole Dr Giovanni Gaviraghi Dr Giuseppe Pollio Dr Graeme Robertson Dr Georg C. Terstappen Dr. von A Bakker · · Zitiert von: 9 — Annette Bakker Dr Andrea Caricasole Dr Giovanni Gaviraghi Dr Giuseppe Pollio Dr Graeme Robertson Dr Georg C. Terstappen Dr.
Label-Free Technologies F or Drug Discovery - Semantic Scholarpdfs.semanticscholar.org › ...
pdfs.semanticscholar.org
von M Cooper — Georg C. Terstappen Introduction Ion Channels as Drug Targets Ion Channel Assays and Screening.
In silico research in drug discoveryScienceDirect.com
www.sciencedirect.com
von GC Terstappen · · Zitiert von: 494 — Review. In silico research in drug discovery. Author links open overlay panel. Georg C. Terstappen a , Angelo Reggiani a. Show more. Add to Mendeley. Share.
Drug Discovery Today | Vol 27, Issue 11, November 2022ScienceDirect.com
www.sciencedirect.com
— ... Georg C. Terstappen, Yipeng Wang. Article : View PDF. Article preview. select article Digital biomarkers for post-licensure safety ...
Twitter-Nachrichten: Cambrian on Twitter: "What motivated Georg C. Terstappen, PhD to ...twitter.com › cambrianbio › status
— What motivated Georg C. Terstappen, PhD to join Cambrian as EVP of Drug Discovery? Cambrian's vibrant team working to lengthen healthspan ...
Target deconvolution strategies in drug discovery | Nature Reviews...
www.nature.com
Georg C. Terstappen, Christina Schlüpen, Roberto Raggiaschi & Giovanni Gaviraghi. Nature Reviews Drug Discovery 6, (November 2007).
Target deconvolution strategies in drug discovery | Nature Reviews...
www.nature.com
Target-based drug discovery has not been as successful as was hoped, in part owing to the complexities of biological systems and disease pathophysiology. This...
(PDF) In silico research in drug discovery. (2000)AI Chat for scientific PDFs | SciSpace
typeset.io
Georg C. Terstappen Nov Assay and Drug Development Technologies. Show Less. TL;DR: These methods will briefly describe fluorescence-based methods ...
ASSAY and Drug Development Technologies | Vol 2, No 5Mary Ann Liebert, Inc.
www.liebertpub.com
Nonradioactive Rubidium Ion Efflux Assay and Its Applications in Drug Discovery and Development · Dr. Georg C. Terstappen. Pages:553–559; Published Online:
BlogsCambrian Bio
www.cambrianbio.com
My journey — developing therapies to extend healthspan. Our former EVP of Drug Discovery, Georg C. Terstappen, shares how his passion drove him to embark on ...
Cambrian BioThe Healthcare Technology Report.
thehealthcaretechnologyreport.com
She effectively manages all aspects of the clinical development process at Cambrian. Georg C. Terstappen, PhD., EVP, Drug Discovery. Georg joined Cambrian in ...
Figure 1 from In silico research in drug discovery.Semantic Scholar
www.semanticscholar.org
Georg C. Terstappen, Angelo Reggiani · Published in TIPS - Trends in… · Chemistry, Computer Science, Medicine.
Target deconvolution strategies in drug discovery,Nature ...X-MOL
www.x-mol.com
Georg C. Terstappen , Christina Schlüpen , Roberto Raggiaschi , Giovanni Gaviraghi. Recognition of some of the limitations of target-based drug discovery has ...
Label-free technologies for drug discovery / [electronic resource]Dhaka University
catalog.library.du.ac.bd
... Georg C Terstappen -- Expanding the Scope of HTMS Methods / Tom G Holt, Jun Wang, Xun Chen, Bernard K Choi, Neil S Geoghagen, Kristian K Jensen, Maxine ...
Not a dilemma: target deconvolution in drug discoveryNational Institutes of Health (NIH) (.gov)
pubmed.ncbi.nlm.nih.gov
von GC Terstappen · · Zitiert von: 3 — Not a dilemma: target deconvolution in drug discovery. Future Med Chem Apr;1(1):7-9. doi: fmc Author. Georg C Terstappen.
Cambrian expands fibrosis pipelineDrug Discovery World
www.ddw-online.com
— ... Georg C Terstappen. The company was founded based on scientific research by Professor Martin Griffin and his team of researchers at Aston ...
CTF Drug Discovery Initiative - The Children's Tumor Foundationctfeurope.org › research › drug-discovery-initiative-...
ctfeurope.org
GEORG C. TERSTAPPEN, PhD. Executive Vice President, Drug Discovery, Cambrian Biopharma. Georg Terstappen is the Executive Vice President of Drug Discovery ...
Cell-Based Assays Using iPSCs for Drug Development and Testing
www.geneeskundeboek.nl
The volume presents a variety of protocols that will be useful to researchers working in the field of disease modeling, drug discovery, and the cell biology of...
Label-Free Technologies for Drug Discovery - AXONaxon.es › ficha › libros › label-free-technologies-for...
axon.es
8 Nonradioactive Rubidium Efflux Assay Technology for Screening of Ion Channels (Georg C. Terstappen) Introduction Ion channels as drug targets.
Speakers | Longevity Leaderswww.lsxleaders.com › longevity-leaders-congress
www.lsxleaders.com
Georg C. Terstappen. EVP, Drug Discovery. Cambrian Biopharma. Stefan G. Tullius, Professor of Surgery, Transplant Surgery, Harvard Medical School ...
Target deconvolution strategies in drug discovery - Document - Gale...
go.gale.com
includes Target deconvolution strategies in drug discovery by Georg C. Terstappen, Christina Schlupen. Click to explore.
Label-free technologies for drug discovery - Medicine sähkökirjat...
old.terkko.helsinki.fi
Terkko Navigator is a medical library community for the University of Helsinki and Helsinki University Central Hospital. Personalize your own library of feeds,...
Target deconvolution strategies in drug discovery - PubMed
pubmed.ncbi.nlm.nih.gov
Recognition of some of the limitations of target-based drug discovery has recently led to the renaissance of a more holistic approach in which complex...
Alle Infos zum Namen "Georg C. Terstappen"
Verwandte Suchanfragen zu Georg C. Terstappen
|
Personen Vorname "Georg" (36045) Name "Terstappen" (77) |
sortiert nach Relevanz / Datum